Marksans Pharma hits 52-week high after USFDA issues EIR for Goa facility



Marksans Pharma hits 52-week high after USFDA issues EIR for Goa facility

Marksans Pharma hits 52-week high after USFDA issues EIR for Goa facility

Marksans Pharma hits 52-week high after USFDA issues EIR for Goa facility

Marksans Pharma hits 52-week high after USFDA issues EIR for Goa facility
Marksans Pharma hits 52-week high after USFDA issues EIR for Goa facility
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Kimia Biosciences reports standalone net profit of Rs 1.44 crore in the June 2024 quarter
Shri Venkatesh Refineries standalone net profit rises 4.35% in the June 2024 quarter

Stock Alert: Sansera Engg, Genus Power Infra, Petronet LNG, CESC, Exide Inds
Indices may start lower on negative global signals